Discussing EU Regulations at AdvaMed Conference (17-19 October 2016)

Posted on 03.11.2016

Edma and Eucomed were jointly represented on a specific EU regulatory panel at the recent AdvaMed Conference. Issues debated at a well-attended session included resources and planning for implementation within businesses, legacy issues, new clinical evidence requirements and capacity issues with notified Bodies going forward. As well as industry, the panel also included EY and a notified body (BSI) and was moderated by Axon Lawyers.